WholesaleInvestor

05 July 2010

Gratuk - Gratuk to short cut time to market for a range of new animal pharmaceuticals

It is common for a new drug to be 10 years in development and cost many $100 millions. However, the Gratuk team have worked with the technology for the past 10 years and now know precisely what they have to do. They are taking products the body makes naturally, and that they have developed before, and producing them in commercial quantities.

What this means is that the Gratuk team is already 7 - 8 years along in the 10 year cycle for these drugs. The funding sought for the projects is for final stage production, fast tracking returns to investors, and giving Gratuk a “first to market” competitive edge over other companies. Direct competitors will still need to develop the base technology to be able to make competitive products. Meanwhile Gratuk will be further along in the next release.

For Further information on Gratuk opportunity please click following link: http://www.wholesaleinvestor.com.au/public_panel/listing_detail/gratuk_technologies_pty_ltd/?id=121